Ademi LLP is investigating Blue Ridge (NYSEAM: BRBS) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with HomeTrust Bancshares.
Blue Ridge shareholders will receive 0.086 of a share of HomeTrust common stock for each share of Blue Ridge common stock, equating to approximately $4.28 per share, based on HomeTrust’s five-day volume-weighted average price of $49.82 as of Aug. 14, 2026, in an all-stock transaction valued at approximately $448.1 million.
Blue Ridge insiders will receive substantial benefits as part of change of control arrangements.
The transaction agreement unreasonably limits competing transactions for Blue Ridge by imposing a significant penalty if Blue Ridge accepts a competing bid. We are investigating the conduct of the Blue Ridge board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.
Join this Action